Riggs Asset Managment Co. Inc. Lyell Immunopharma, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $335 Million
- Q2 2024
A detailed history of Riggs Asset Managment Co. Inc. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 150 shares of LYEL stock, worth $226. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$226
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding LYEL
# of Institutions
123Shares Held
145MCall Options Held
2.6KPut Options Held
7.5K-
Mwg Management Ltd. Washington, DC20.2MShares$30.4 Million31.93% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$22.8 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$22.8 Million16.63% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$20.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.4MShares$20.2 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $374M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...